These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20736462)

  • 1. FDA opioid safety plan promotes patient, physician education to prevent abuse.
    Kuehn BM
    JAMA; 2010 Aug; 304(8):845. PubMed ID: 20736462
    [No Abstract]   [Full Text] [Related]  

  • 2. Scientists, officials eye tools aimed at combating abuse of painkillers.
    Kuehn BM
    JAMA; 2012 Jan; 307(1):19-21. PubMed ID: 22215154
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA Boxed Warning for Immediate-Release Opioids.
    Food And Drug Administration Public Health Service U S Department Of Health And Human Services
    J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):141-5. PubMed ID: 27301692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can prescription drug monitoring programs help limit opioid abuse?
    Gugelmann HM; Perrone J
    JAMA; 2011 Nov; 306(20):2258-9. PubMed ID: 22110107
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA committee: More restrictions needed on hydrocodone combination products.
    Kuehn BM
    JAMA; 2013 Mar; 309(9):862. PubMed ID: 23462764
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety plan for opioids meets resistance: opioid-linked deaths continue to soar.
    Kuehn BM
    JAMA; 2010 Feb; 303(6):495-7. PubMed ID: 20145218
    [No Abstract]   [Full Text] [Related]  

  • 7. Curbing the opioid epidemic in the United States: the risk evaluation and mitigation strategy (REMS).
    Nelson LS; Perrone J
    JAMA; 2012 Aug; 308(5):457-8. PubMed ID: 22851109
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA tightens indications for using long-acting and extended-release opioids to treat chronic pain.
    Kuehn BM
    JAMA; 2013 Oct; 310(15):1547-8. PubMed ID: 24129447
    [No Abstract]   [Full Text] [Related]  

  • 9. Class-wide REMS for extended-release and long-acting opioids: potential impact on pharmacies.
    Matthews ML
    J Am Pharm Assoc (2003); 2013; 53(1):e1-7. PubMed ID: 23636166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid analgesics--risky drugs, not risky patients.
    Dowell D; Kunins HV; Farley TA
    JAMA; 2013 Jun; 309(21):2219-20. PubMed ID: 23700072
    [No Abstract]   [Full Text] [Related]  

  • 11. Q&A with Peter Holden.
    Holden P; Stempniak M
    Hosp Health Netw; 2016 Mar; 90(3):25. PubMed ID: 27180400
    [No Abstract]   [Full Text] [Related]  

  • 12. Federal plan for prescriber education on opioids misses opportunities.
    Becker WC; Fiellin DA
    Ann Intern Med; 2012 Aug; 157(3):205-6. PubMed ID: 22868838
    [No Abstract]   [Full Text] [Related]  

  • 13. Coupling Policymaking with Evaluation - The Case of the Opioid Crisis.
    Barnett ML; Gray J; Zink A; Jena AB
    N Engl J Med; 2017 Dec; 377(24):2306-2309. PubMed ID: 29236636
    [No Abstract]   [Full Text] [Related]  

  • 14. ER/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health Outcomes.
    Cepeda MS; Coplan PM; Kopper NW; Maziere JY; Wedin GP; Wallace LE
    Pain Med; 2017 Jan; 18(1):78-85. PubMed ID: 27373304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rethinking opioid prescribing to protect patient safety and public health.
    Alexander GC; Kruszewski SP; Webster DW
    JAMA; 2012 Nov; 308(18):1865-6. PubMed ID: 23150006
    [No Abstract]   [Full Text] [Related]  

  • 16. The Opioid Epidemic.
    Stempniak M
    Hosp Health Netw; 2016 Mar; 90(3):22-4, 26-9. PubMed ID: 27180399
    [No Abstract]   [Full Text] [Related]  

  • 17. Addressing prescription opioid overdose: data support a comprehensive policy approach.
    Jones CM; Lurie P; Woodcock J
    JAMA; 2014 Nov; 312(17):1733-4. PubMed ID: 25275855
    [No Abstract]   [Full Text] [Related]  

  • 18. Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment.
    Volkow ND; McLellan TA
    JAMA; 2011 Apr; 305(13):1346-7. PubMed ID: 21467287
    [No Abstract]   [Full Text] [Related]  

  • 19. Physician continuing education to reduce opioid misuse, abuse, and overdose: Many opportunities, few requirements.
    Davis CS; Carr D
    Drug Alcohol Depend; 2016 Jun; 163():100-7. PubMed ID: 27137406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manufacturers argue against mandatory training for opioid prescribers.
    Traynor K
    Am J Health Syst Pharm; 2010 Jan; 67(2):96. PubMed ID: 20065261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.